EUVIMEDEUVIMED entdecken
Validierungsstudie

Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool

Milie M Fang iD, Jordan Gillespie iD, Robyn Okereke iD, Julie Dhossche iD, Emile Latour iD, Chien-Chia Chuang iD, Jerome Msihid iD, Zhixiao Wang iD, Eric L Simpson iD

Clinical and Experimental Dermatology · 2026

DOI: 10.1093/ced/llag289 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Milie M Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Oregon Health & Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Caregivers. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Oregon Health & Science Institutional Review Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Atopic Dermatitis Control Tool (ADCT) is a validated six-item tool used in clinical trials to assess eczema control in adolescents and adults. Two versions of the ADCT were recently developed using a US Food and Drug Administration-recommended methodology. One is intended for use with caregivers of children aged 6 months to 11 years (the Caregiver ADCT; score range 0–24; higher scores indicate worse control; recall period the past 7 days). The other, the Child Eczema Control Tool (ECT), is intended for use with children aged 8 to 11 years. We conducted the first psychometric validation of the Caregiver ADCT (first 100 caregivers recruited), which demonstrated no floor or ceiling effects in response distributions, except for a floor effect for ‘sleep-trouble nights’ (47% selected the least severe option; n = 47/100). There were strong inter-item correlations (r ≥ 0.57; P < 0.001) and construct validity (r ≥ 0.59; P < 0.001), consistent with a priori hypotheses. The Caregiver ADCT showed strong internal consistency (Cronbach’s α = 0.92, 95% confidence interval 0.90–0.94). A score ≥ 7 was identified as the optimal threshold for identifying children whose eczema was ‘not in control’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicCaregiversHumansChildPsychometricsFemaleMaleChild, PreschoolReproducibility of ResultsInfantSurveys and QuestionnairesSeverity of Illness IndexAdult

Autor:innen und Institutionen

  • Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
  • Department of Dermatology and Pediatrics, Oregon Health & Science University, Portland, OR, USA.
  • Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Sanofi, Cambridge, MA, USA.
  • Sanofi, Gentilly, France.
  • Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.

ORCID-Profile: Milie M Fang, Jordan Gillespie, Robyn Okereke, Julie Dhossche, Emile Latour, Chien-Chia Chuang, Jerome Msihid, Zhixiao Wang, Eric L Simpson

Förderung

  • Oregon Health & Science Institutional Review Board

Zitieren

APA

Fang, M. M., Gillespie, J., Okereke, R., Dhossche, J., Latour, E., Chuang, C. C., Msihid, J., Wang, Z., & Simpson, E. L. (2026). Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag289

Vancouver

Fang MM, Gillespie J, Okereke R, Dhossche J, Latour E, Chuang CC, et al. Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag289

BibTeX
@article{Fang2026,
  author = {Fang, Milie M and Gillespie, Jordan and Okereke, Robyn and Dhossche, Julie and Latour, Emile and Chuang, Chien-Chia and Msihid, Jerome and Wang, Zhixiao and Simpson, Eric L},
  title = {Initial psychometric validation of the Caregiver Atopic Dermatitis Control Tool},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag289}
}
Kostenlos starten →